Paraneoplastic & Metastatic Patterns
- Most cancers spread to a predictable short list of places: lung, liver, bone, brain, lymph nodes, and the adrenals. Learn the regulars and you've covered most of the work.
- The route a tumor takes (lymphatics, bloodstream, across a body cavity, or along nerves) predicts where you'll find the deposits.
- Bone metastases come in two flavors — bone-eating (lytic) and bone-building (sclerotic) — and which one you see narrows the list of likely primaries.
- A "paraneoplastic" finding is the body misbehaving at a distance from the tumor, sometimes before the tumor itself is visible. The imaging clue is usually a new neurologic deficit with a suspiciously normal-looking scan.
- A single weird spot in an unusual place, in someone with known cancer, is a metastasis until proven otherwise — but don't let that reflex make you miss the boring benign mimic.
Cancer is, annoyingly, a creature of habit. You'd think a runaway cell could end up anywhere, but in practice tumors spread to the same handful of neighborhoods over and over, like a tourist who only ever visits the same five cities. Once you know the regular stops, reading an oncology study stops feeling like a scavenger hunt and starts feeling like checking off a guest list.
The usual destinations
If you remember nothing else about where metastases go, remember the big six: lungs, liver, bone, brain, lymph nodes, and adrenal glands. These organs are popular for a simple plumbing reason — they're the first big filters downstream of wherever blood and lymph drain. The lungs catch whatever the veins carry back to the heart; the liver catches everything the gut sends through the portal vein. Filters clog. That's the whole concept.
So the gut cancers (colon, pancreas, stomach) love the liver first, because that's literally where their venous drainage dumps out. Lung, breast, kidney, and melanoma are the famous brain-and-bone travelers. Knowing the drainage tells you the destination.
A useful mental shortcut: blood-borne spread tends to land in organs with rich blood supply and a filtering job (lungs, liver, bone marrow, brain), while lymphatic spread marches node to node along predictable chains. Match the pattern you see to the route, and the primary often reveals itself.
Four ways to travel
Tumors don't teleport; they take roads. There are basically four.
| Route | How it spreads | Classic imaging footprint |
|---|---|---|
| Lymphatic | Cell-by-cell up node chains | Enlarged/round nodes along expected drainage; lymphangitic spread thickening the lung's scaffolding |
| Hematogenous | Through the bloodstream | Round nodules scattered in lung, liver, bone, or brain |
| Transcoelomic | Seeding across a body cavity | Peritoneal nodules, omental "caking," ascites |
| Perineural | Crawling along nerves | Subtle nerve thickening/enhancement, widened foramina |
The cavity-seeding one is worth a second look, because it's sneaky. When ovarian or gastric cancer sheds cells into the belly, those cells ride the peritoneal fluid currents and plaster the omentum into a thick, ugly sheet — radiologists call it omental caking, which is a delightfully appetizing name for something that is the opposite of appetizing.
Bone metastases: eaters vs builders
Bone mets are common enough that you'll meet them constantly, and they come in two personalities. Lytic lesions eat bone away, leaving a punched-out hole or moth-eaten edge. Sclerotic (blastic) lesions do the opposite — they trigger frantic bone building, leaving a dense white blob. Many cancers do a bit of both (mixed).
The flavor narrows your suspect list. A few reliable associations worth knowing:
| Pattern | Think of these primaries |
|---|---|
| Sclerotic (dense, white) | Prostate; some breast |
| Lytic (destructive, dark) | Kidney; thyroid; lung; multiple myeloma |
| Mixed | Breast is the great fence-sitter |
Multiple myeloma is the classic trickster on bone imaging: its lytic, marrow-replacing lesions are famously cold on a routine bone scan, because the scan lights up bone-building activity and myeloma doesn't bother building. If you're hunting myeloma, a normal bone scan is reassuring of exactly nothing — that's a job for skeletal survey, CT, MRI, or FDG-PET.
Paraneoplastic patterns: trouble at a distance
Here's the genuinely strange category. A paraneoplastic syndrome is the body reacting to a tumor somewhere other than where the tumor is — usually because the cancer is pumping out hormones, or because the immune system, while attacking the tumor, gets confused and attacks normal tissue that looks similar. The deposits aren't metastases; they're collateral damage.
For imaging, the highest-yield version is paraneoplastic limbic encephalitis and its cousins: a patient develops new neurologic or psychiatric symptoms, and the brain MRI shows inflammation in places like the medial temporal lobes — often with no tumor visible on the brain scan at all, because the troublemaker is hiding in the chest or pelvis.
When a paraneoplastic neurologic syndrome is suspected but the brain looks bland, the search shifts to finding the occult primary. Whole-body FDG-PET earns its keep here, because a small, otherwise-invisible tumor can still glow with metabolic activity.
This is exactly the kind of problem FDG-PET was built for, and it's worth pairing this page with FDG-PET in oncology once the patterns feel comfortable.
The trap: not everything is a metastasis
The reflex "known cancer + new spot = metastasis" is correct often enough to be dangerous, because it makes you sloppy about the times it's wrong. A bright liver lesion can be a harmless cyst or hemangioma. A sclerotic vertebral focus can be a bone island that's been there for decades. An enlarged node can simply be reacting to infection.
A solitary lesion in a patient with cancer deserves the same scrutiny you'd give it in anyone else. Default to "metastasis until proven otherwise," but stay honest about benign mimics — and when it changes management, get tissue.
The overarching skill here is pattern recognition feeding into a staging framework: count the deposits, name their distribution, decide what it means for the patient. If the bookkeeping side feels fuzzy, the companion read is staging principles & TNM. Learn the regular destinations, learn the four roads tumors travel to reach them, and most oncologic imaging becomes a story you can actually follow.